These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 30583585)

  • 1. Mutual Expression of ALDH1A1, LOX, and Collagens in Ovarian Cancer Cell Lines as Combined CSCs- and ECM-Related Models of Drug Resistance Development.
    Sterzyńska K; Klejewski A; Wojtowicz K; Świerczewska M; Nowacka M; Kaźmierczak D; Andrzejewska M; Rusek D; Brązert M; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of
    Nowacka M; Ginter-Matuszewska B; Świerczewska M; Sterzyńska K; Nowicki M; Januchowski R
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations.
    Świerczewska M; Sterzyńska K; Wojtowicz K; Kaźmierczak D; Iżycki D; Nowicki M; Zabel M; Januchowski R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027318
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
    Januchowski R; Wojtowicz K; Sterzyſska K; Sosiſska P; Andrzejewska M; Zawierucha P; Nowicki M; Zabel M
    Int J Biochem Cell Biol; 2016 Sep; 78():248-259. PubMed ID: 27443528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines.
    Sterzyńska K; Klejewski A; Wojtowicz K; Świerczewska M; Andrzejewska M; Rusek D; Sobkowski M; Kędzia W; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of collagen, lysyl oxidase and MMP-2 in human periodontal ligament cells by low- and high-level mechanical stretching.
    Chen YJ; Jeng JH; Chang HH; Huang MY; Tsai FF; Yao CC
    J Periodontal Res; 2013 Aug; 48(4):466-74. PubMed ID: 23190051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperine Targets Different Drug Resistance Mechanisms in Human Ovarian Cancer Cell Lines Leading to Increased Sensitivity to Cytotoxic Drugs.
    Wojtowicz K; Sterzyńska K; Świerczewska M; Nowicki M; Zabel M; Januchowski R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.
    Landen CN; Goodman B; Katre AA; Steg AD; Nick AM; Stone RL; Miller LD; Mejia PV; Jennings NB; Gershenson DM; Bast RC; Coleman RL; Lopez-Berestein G; Sood AK
    Mol Cancer Ther; 2010 Dec; 9(12):3186-99. PubMed ID: 20889728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
    Januchowski R; Świerczewska M; Sterzyńska K; Wojtowicz K; Nowicki M; Zabel M
    J Cancer; 2016; 7(10):1295-310. PubMed ID: 27390605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and Old Genes Associated with Primary and Established Responses to Paclitaxel Treatment in Ovarian Cancer Cell Lines.
    Świerczewska M; Klejewski A; Brązert M; Kaźmierczak D; Iżycki D; Nowicki M; Zabel M; Januchowski R
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29649113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALDH1A1 maintains ovarian cancer stem cell-like properties by altered regulation of cell cycle checkpoint and DNA repair network signaling.
    Meng E; Mitra A; Tripathi K; Finan MA; Scalici J; McClellan S; Madeira da Silva L; Reed E; Shevde LA; Palle K; Rocconi RP
    PLoS One; 2014; 9(9):e107142. PubMed ID: 25216266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human colorectal cancer progression correlates with LOX-induced ECM stiffening.
    Wei B; Zhou X; Liang C; Zheng X; Lei P; Fang J; Han X; Wang L; Qi C; Wei H
    Int J Biol Sci; 2017; 13(11):1450-1457. PubMed ID: 29209148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines.
    Kazmierczak D; Jopek K; Sterzynska K; Ginter-Matuszewska B; Nowicki M; Rucinski M; Januchowski R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licofelone Enhances the Efficacy of Paclitaxel in Ovarian Cancer by Reversing Drug Resistance and Tumor Stem-like Properties.
    Hirst J; Pathak HB; Hyter S; Pessetto ZY; Ly T; Graw S; Koestler DC; Krieg AJ; Roby KF; Godwin AK
    Cancer Res; 2018 Aug; 78(15):4370-4385. PubMed ID: 29891506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells.
    Sharma-Bhandari A; Park SH; Kim JY; Oh J; Kim Y
    Int J Mol Med; 2015 Dec; 36(6):1664-70. PubMed ID: 26497171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines.
    Sterzyńska K; Kaźmierczak D; Klejewski A; Świerczewska M; Wojtowicz K; Nowacka M; Brązert J; Nowicki M; Januchowski R
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
    Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
    J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer.
    De Donato M; Petrillo M; Martinelli E; Filippetti F; Zannoni GF; Scambia G; Gallo D
    Gynecol Oncol; 2017 Jul; 146(1):170-178. PubMed ID: 28495238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.